V. Chandrodhayam, K. A. Ashok Kumar, K. Rao, Aditya Samantaray
{"title":"微创入路治疗中央巨细胞肉芽肿1例","authors":"V. Chandrodhayam, K. A. Ashok Kumar, K. Rao, Aditya Samantaray","doi":"10.25259/jade_37_2022","DOIUrl":null,"url":null,"abstract":"A rare, benign, and prying intrabony lesion that affects both the maxilla and the mandible, the central giant cell granuloma, is brought on by reactive or developmental defects. The most popular form of treatment is surgical curettage or, in cases of aggressive lesions, resection, but it is frequently impossible to avoid causing adverse impairment to the teeth or jaws, and recurrences seem more common. As a result, several subcutaneous administration methods using interferon alpha or calcitonin are documented in a number of case studies with varying degrees of efficacy. In this article, intra-lesional corticosteroid is used with no recurrence over a 2-year follow-up period to emphasize the value of a minimally invasive first line treatment.","PeriodicalId":163007,"journal":{"name":"Journal of Academy of Dental Education","volume":"108 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A minimally invasive approach on central giant cell granuloma: A case report\",\"authors\":\"V. Chandrodhayam, K. A. Ashok Kumar, K. Rao, Aditya Samantaray\",\"doi\":\"10.25259/jade_37_2022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A rare, benign, and prying intrabony lesion that affects both the maxilla and the mandible, the central giant cell granuloma, is brought on by reactive or developmental defects. The most popular form of treatment is surgical curettage or, in cases of aggressive lesions, resection, but it is frequently impossible to avoid causing adverse impairment to the teeth or jaws, and recurrences seem more common. As a result, several subcutaneous administration methods using interferon alpha or calcitonin are documented in a number of case studies with varying degrees of efficacy. In this article, intra-lesional corticosteroid is used with no recurrence over a 2-year follow-up period to emphasize the value of a minimally invasive first line treatment.\",\"PeriodicalId\":163007,\"journal\":{\"name\":\"Journal of Academy of Dental Education\",\"volume\":\"108 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Academy of Dental Education\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/jade_37_2022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Academy of Dental Education","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/jade_37_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A minimally invasive approach on central giant cell granuloma: A case report
A rare, benign, and prying intrabony lesion that affects both the maxilla and the mandible, the central giant cell granuloma, is brought on by reactive or developmental defects. The most popular form of treatment is surgical curettage or, in cases of aggressive lesions, resection, but it is frequently impossible to avoid causing adverse impairment to the teeth or jaws, and recurrences seem more common. As a result, several subcutaneous administration methods using interferon alpha or calcitonin are documented in a number of case studies with varying degrees of efficacy. In this article, intra-lesional corticosteroid is used with no recurrence over a 2-year follow-up period to emphasize the value of a minimally invasive first line treatment.